<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 27, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03408808</url>
  </required_header>
  <id_info>
    <org_study_id>1/091/17</org_study_id>
    <nct_id>NCT03408808</nct_id>
  </id_info>
  <brief_title>Dorsal Wrist Ganglia; Aspiration Alone vs Aspiration and Injection of Platelet Rich Plasma</brief_title>
  <official_title>Dorsal Wrist Ganglia; Aspiration Alone vs Aspiration and Injection of Platelet Rich Plasma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aberdeen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NHS Grampian</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Arthrex, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aberdeen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study to examine the efficacy of Platelet Rich Plasma (PRP) to reduce recurrence in dorsal&#xD;
      wrist ganglia (DWG). We will compare aspiration alone and aspiration with injection of PRP.&#xD;
&#xD;
      We plan to recruit a maximum of 200 patients. We will assess the efficacy by contacting the&#xD;
      patients by email or telephone at 6 weeks and 12 months. They will be asked to complete a&#xD;
      questionnaire and a Patient Evaluated Measure score (PEMS). Adverse events will be screened&#xD;
      for/ managed by a telephone call +/- review as necessary between 7 and 14 days.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Patient selection All hand referrals vetted by Mr Lawrie or Miss Miller, those for&#xD;
           dorsal wrist ganglia sent a letter of invitation and patient information. Patients&#xD;
           responding to the letter with interested given an appointment at a special trial clinic.&#xD;
&#xD;
           Contact details will be provided to allow any issues to be clarified discussed before&#xD;
           attendance at clinic if the patient desires.&#xD;
&#xD;
        2. Assess eligibility/ enrolment in study - clinic visit 1&#xD;
&#xD;
             1. All patients assessed by the chief investigator Mr David Lawrie (DFML) or Miss&#xD;
                Katharine Hamlin (KH).&#xD;
&#xD;
             2. Clinical assessment of presence of ganglion.&#xD;
&#xD;
             3. Ensure not meeting exclusion criteria.&#xD;
&#xD;
             4. If eligible and willing to complete study commitments discuss study and answer&#xD;
                questions.&#xD;
&#xD;
             5. Once we are happy the patient has understanding of the study and its risks then the&#xD;
                patient will be asked if they wish to enrol or if they would like more time to&#xD;
                consider.&#xD;
&#xD;
             6. If they are willing to participate they will then be offered treatment in the same&#xD;
                visit or a return visit&#xD;
&#xD;
        3. Intervention - clinic visit 1 or 2&#xD;
&#xD;
             1. Check understanding and continuing desire to participate in study if 2nd visit.&#xD;
&#xD;
             2. Complete consent form.&#xD;
&#xD;
             3. Patient fills out a PEM score and demographics collected on SOS (Surgical Outcomes&#xD;
                System - Arthrex).&#xD;
&#xD;
             4. Randomisation.&#xD;
&#xD;
             5. If in PRP group 15ml blood sample taken with Arthrex ACP double syringe and&#xD;
                processed (see processing instructions in Appendix.9.&#xD;
&#xD;
             6. Aspiration.&#xD;
&#xD;
             7. If in PRP group - Injection of PRP (the same volume as aspirated).&#xD;
&#xD;
             8. Pressure dressing with gauze, wool and crepe for 48 hours.&#xD;
&#xD;
        4. Adverse event screening/ management Patients are offered two options at the treatment&#xD;
           visit.&#xD;
&#xD;
      1. Routine review at 10 - 14 days at the clinic or 2. Telephone review at 7 days by Miss&#xD;
      Katharine Hamlin who will have performed the procedure.&#xD;
&#xD;
      On telephone review if the patient is entirely happy that there are no concerns then follow&#xD;
      up will proceed by email or telephone as below.&#xD;
&#xD;
      If any concerns are raised, or if the patient desires, a face to face review will be arranged&#xD;
      ideally within 24 hours but no longer than 72 hours. Recurrence or other outcomes will not be&#xD;
      assessed at this time.&#xD;
&#xD;
      5. SOS/ Email/ Telephone interview - 1 (6 weeks)&#xD;
&#xD;
      a) Ganglion questionnaire b) PEM score c) Note any adverse events&#xD;
&#xD;
      6. SOS/ Email /Telephone interview - 2 (12 months)&#xD;
&#xD;
        1. Ganglion questionnaire&#xD;
&#xD;
        2. PEM score&#xD;
&#xD;
        3. Note any adverse events&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 5, 2018</start_date>
  <completion_date type="Anticipated">December 5, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 5, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomisaed controlled trial with two arms. Control - Aspiration alone. Intervention - aspiration plus injection of platelet righ plasma.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The outcomes assessor will be blinded to the treatment received.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence</measure>
    <time_frame>6 weeks</time_frame>
    <description>Has the ganglion returned?</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recurrence</measure>
    <time_frame>12 months</time_frame>
    <description>Has the ganglion returned?</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PEM Score</measure>
    <time_frame>6 weeks</time_frame>
    <description>Patient reported measure of hand symptoms and function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PEM Score</measure>
    <time_frame>12 months</time_frame>
    <description>Patient reported measure of hand symptoms and function</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Ganglion of Wrist</condition>
  <arm_group>
    <arm_group_label>Aspiration alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients will have their dorsal wrist ganglion aspirated and then pressure dressing for 48 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aspiration plus platelet rich plasma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients will have their dorsal wrist ganglion aspirated, and then injected with platelet rich plasma (derived from a blood sample taken at the same visit) and then pressure dressing for 48 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Platelet rich plasma</intervention_name>
    <description>Aspiration of ganglion and injection with platelet rich plasma.</description>
    <arm_group_label>Aspiration plus platelet rich plasma</arm_group_label>
    <other_name>PRP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Aspiration alone</intervention_name>
    <description>Aspiration of the ganglion</description>
    <arm_group_label>Aspiration alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Solitary dorsal wrist ganglion.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Underlying wrist or ipsilateral arm pathology.&#xD;
&#xD;
          -  Unable to consent to treatment.&#xD;
&#xD;
          -  Unable or unwilling to attend follow up visits.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katharine Hamlin, MBChB</last_name>
    <role>Principal Investigator</role>
    <affiliation>NHS Grampian</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patricia Burns</last_name>
    <phone>+441224554362</phone>
    <email>researchgovernance@abdn.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>NHS Grampian</name>
      <address>
        <city>Aberdeen</city>
        <zip>AB25 2ZB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Burns</last_name>
      <phone>1224554362</phone>
    </contact>
    <investigator>
      <last_name>Katharine Hamlin, MBChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Meena S, Gupta A. Dorsal wrist ganglion: Current review of literature. J Clin Orthop Trauma. 2014 Jun;5(2):59-64. doi: 10.1016/j.jcot.2014.01.006. Epub 2014 Jun 3. Review.</citation>
    <PMID>25983472</PMID>
  </reference>
  <reference>
    <citation>Janzon L, Niechajev IA. Wrist ganglia. Incidence and recurrence rate after operation. Scand J Plast Reconstr Surg. 1981;15(1):53-6.</citation>
    <PMID>7268314</PMID>
  </reference>
  <reference>
    <citation>Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004 Apr;62(4):489-96. Review.</citation>
    <PMID>15085519</PMID>
  </reference>
  <reference>
    <citation>Freymiller EG, Aghaloo TL. Platelet-rich plasma: ready or not? J Oral Maxillofac Surg. 2004 Apr;62(4):484-8. Review.</citation>
    <PMID>15085518</PMID>
  </reference>
  <reference>
    <citation>Yu W, Wang J, Yin J. Platelet-rich plasma: a promising product for treatment of peripheral nerve regeneration after nerve injury. Int J Neurosci. 2011 Apr;121(4):176-80. doi: 10.3109/00207454.2010.544432. Epub 2011 Jan 19.</citation>
    <PMID>21244302</PMID>
  </reference>
  <reference>
    <citation>Valente Duarte de Sousa IC, Tosti A. New investigational drugs for androgenetic alopecia. Expert Opin Investig Drugs. 2013 May;22(5):573-89. doi: 10.1517/13543784.2013.784743. Epub 2013 Apr 4. Review. Erratum in: Expert Opin Investig Drugs. 2015 May;24(5):735.</citation>
    <PMID>23550739</PMID>
  </reference>
  <reference>
    <citation>Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225-8.</citation>
    <PMID>11813662</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 16, 2018</study_first_submitted>
  <study_first_submitted_qc>January 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 24, 2018</study_first_posted>
  <last_update_submitted>February 22, 2021</last_update_submitted>
  <last_update_submitted_qc>February 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>wrist</keyword>
  <keyword>ganglion</keyword>
  <keyword>platelet rich plasma</keyword>
  <keyword>aspiration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ganglion Cysts</mesh_term>
    <mesh_term>Synovial Cyst</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 3, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/08/NCT03408808/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <pending_results>
    <submitted>March 26, 2021</submitted>
    <returned>April 21, 2021</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

